Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Choosing CAR T vs bispecifics across lymphomas
Dr Lunning outlines evolving roles of CAR T and bispecific antibodies in diffuse large B-cell, mantle cell, and follicular lymphoma.
Play episode from 22:24
Transcript
